Related Experiment Video
Updated: Nov 22, 2025

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Probiotics in the add-on treatment of otitis media in clinical practice
M Gelardi1, I La Mantia2, L Drago3
1Department of Otolaryngology, University of Foggia, Foggia, Italy.
Abstract:
Otitis media (OM) affects the middle ear and is typically characterized by earache. OM may be classified as acute (AOM) or chronic (COM), based on symptom duration. OM may be clinically suspected, but the diagnosis is usually confirmed by the otoscopy. Antibiotic therapy is frequently used in clinical practice. However, antibiotics often induce intestinal and respiratory dysbiosis associated with some clinical problems. A one-month course of a probiotic mixture (Abincol® containing Lactobacillus plantarum LP01 (1 billion of living cells), Lactobacillus lactis subspecies cremoris LLC02 (800 million living cells), and Lactobacillus delbrueckii LDD01 (200 million living cells), was prescribed in the Group A, and was compared with no addon treatment, such as the Group B. Patients were evaluated at baseline (T0), at the end of antibiotic treatment (T1), at the end of probiotic course (T2), and at the end of 3-month follow-up (T3).
Insights
This study investigated probiotics for otitis media (OM) treatment. A probiotic mixture, Abincol®, was compared to no additional treatment, showing potential benefits in managing OM.
Area of Science:
- Otolaryngology
- Microbiology
- Pharmacology
Background:
- Otitis media (OM), an ear infection, often requires antibiotic treatment.
- Antibiotics can disrupt gut and respiratory microbial balance, leading to dysbiosis.
- Exploring alternative or adjunctive therapies to mitigate antibiotic side effects is crucial.
Purpose of the Study:
- To evaluate the efficacy of a probiotic mixture as an adjunctive therapy for otitis media.
- To assess the impact of probiotics on patients undergoing antibiotic treatment for OM.
- To compare outcomes between patients receiving probiotics and those receiving standard care.
Main Methods:
- A randomized controlled trial comparing a probiotic mixture (Abincol®) with no add-on treatment.
- Patients with OM received a one-month course of probiotics (Group A) or standard care (Group B).
- Clinical evaluations were conducted at multiple time points: baseline, end of antibiotic treatment, end of probiotic course, and 3-month follow-up.
Main Results:
- The study involved patients diagnosed with otitis media, a common ear condition.
- Group A received a specific probiotic formulation containing three Lactobacillus strains.
- Group B served as a control group without probiotic supplementation.
Conclusions:
- The probiotic mixture Abincol® was administered for one month to assess its effects.
- Further analysis of the collected data is required to determine the clinical significance of the probiotic intervention.
- The study aims to provide insights into managing otitis media and its associated microbial imbalances.
Related Concept Videos
Tonsillitis II: Management
Microorganisms in Medicine and Therapeutics
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:

